{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:38:16Z","timestamp":1791563896405,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Genetic testing can offer early diagnosis and subsequent treatment of rare neuromuscular diseases. Options for these tests could be improved by understanding the preferences of patients for the features of different genetic tests, especially features that increase information available to patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed an online discrete-choice experiment using key attributes of currently available tests for Pompe disease with six test attributes: number of rare muscle diseases tested for with corresponding probability of diagnosis, treatment availability, time from testing to results, inclusion of secondary findings, necessity of a muscle biopsy, and average time until final diagnosis if the first test is negative. Respondents were presented a choice between two tests with different costs, with respondents randomly assigned to one of two costs. Data were analyzed using random-parameters logit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 600 online respondents, aged 18 to 50 years, were recruited from the U.S. general population and included in the final analysis. Tests that targeted more diseases, required less time from testing to results, included information about unrelated health risks, and were linked to shorter time to the final diagnosis were preferred and associated with diseases with available treatment. Men placed relatively more importance than women on tests for diseases with available treatments. Most of the respondents would be more willing to get a genetic test that might return unrelated health information, with women exhibiting a statistically significant preference. While respondents were sensitive to cost, 30% of the sample assigned to the highest cost was willing to pay $500 for a test that could offer a diagnosis almost 2 years earlier.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results highlight the value people place on the information genetic tests can provide about their health, including faster diagnosis of rare, unexplained muscle weakness, but also the value of tests for multiple diseases, diseases without treatments, and incidental findings. An earlier time to diagnosis can provide faster access to treatment and an end to the diagnostic journey, which patients highly prefer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03160-7","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T12:02:14Z","timestamp":1713787334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The value of knowing: preferences for genetic testing to diagnose rare muscle diseases"],"prefix":"10.1186","volume":"19","author":[{"given":"Carol","family":"Mansfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Baranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6691","authenticated-orcid":false,"given":"Susan","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"An Haack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"3160_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12911-016-0268-5","volume":"16","author":"L Grigull","year":"2016","unstructured":"Grigull L, Lechner W, Petri S, Kollewe K, Dengler R, Mehmecke S, et al. Diagnostic support for selected neuromuscular diseases using answer-pattern recognition and data mining techniques: a proof of concept multicenter prospective trial. BMC Med Inf Decis Mak. 2016;16:31.","journal-title":"BMC Med Inf Decis Mak"},{"key":"3160_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12883-015-0473-3","volume":"15","author":"Y Qian","year":"2015","unstructured":"Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh WS. Understanding the experiences and needs of individuals with spinal muscular atrophy and their parents: a qualitative study. BMC Neurol. 2015;15:217.","journal-title":"BMC Neurol"},{"issue":"5","key":"3160_CR3","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/mus.25725","volume":"56","author":"S Paganoni","year":"2017","unstructured":"Paganoni S, Nicholson K, Leigh F, Swoboda K, Chad D, Drake K, et al. Developing multidisciplinary clinics for neuromuscular care and research. Muscle Nerve. 2017;56(5):848\u201358.","journal-title":"Muscle Nerve"},{"issue":"6","key":"3160_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/mus.25387","volume":"54","author":"CD Kassardjian","year":"2016","unstructured":"Kassardjian CD, Amato AA, Boon AJ, Childers MK, Klein CJ, Committee APP. The utility of genetic testing in neuromuscular disease: a consensus statement from the AANEM on the clinical utility of genetic testing in diagnosis of neuromuscular disease. Muscle Nerve. 2016;54(6):1007\u20139.","journal-title":"Muscle Nerve"},{"issue":"3","key":"3160_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1590\/1678-4685-GMB-2016-0019","volume":"39","author":"M Zatz","year":"2016","unstructured":"Zatz M, Passos-Bueno MR, Vainzof M. Neuromuscular disorders: genes, genetic counseling and therapeutic trials. Genet Mol Biology. 2016;39(3):339\u201348.","journal-title":"Genet Mol Biology"},{"issue":"3","key":"3160_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pmr.2012.06.011","volume":"23","author":"CM McDonald","year":"2012","unstructured":"McDonald CM. Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases. Phys Med Rehabil Clin North Am. 2012;23(3):495\u2013563.","journal-title":"Phys Med Rehabil Clin North Am"},{"key":"3160_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","volume":"6","author":"JA Lim","year":"2014","unstructured":"Lim JA, Li L, Raben N. Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci. 2014;6:177.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3160_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","volume":"103","author":"U Mellies","year":"2009","unstructured":"Mellies U, Lofaso F. Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir Med. 2009;103(4):477\u201384.","journal-title":"Respir Med"},{"issue":"2","key":"3160_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","volume":"189","author":"DD Fuller","year":"2013","unstructured":"Fuller DD, ElMallah MK, Smith BK, Corti M, Lawson LA, Falk DJ, et al. The respiratory neuromuscular system in pompe disease. Respir Physiol Neurobiol. 2013;189(2):241\u20139.","journal-title":"Respir Physiol Neurobiol"},{"issue":"4","key":"3160_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pedneo.2013.03.009","volume":"54","author":"YH Chien","year":"2013","unstructured":"Chien YH, Hwu WL, Lee NC. Pompe disease: early diagnosis and early treatment make a difference. Pediatr Neonatol. 2013;54(4):219\u201327.","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"3160_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/ana.24303","volume":"77","author":"A Ankala","year":"2015","unstructured":"Ankala A, da Silva C, Gualandi F, Ferlini A, Bean LJ, Collins C, et al. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield. Ann Neurol. 2015;77(2):206\u201314.","journal-title":"Ann Neurol"},{"key":"3160_CR12","unstructured":"The Condition Review Workgroup. Evidence Report: Newborn Screening for Pompe Disease. 2013."},{"issue":"4","key":"3160_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1017\/cjn.2016.37","volume":"43","author":"M Tarnopolsky","year":"2016","unstructured":"Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, et al. Pompe disease: diagnosis and management. Evidence-based guidelines from a Canadian Expert Panel. Can J Neurol Sci \/ J Canadien Des Sci Neurologiques. 2016;43(4):472\u201385.","journal-title":"Can J Neurol Sci \/ J Canadien Des Sci Neurologiques"},{"issue":"8","key":"3160_CR14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41436-020-0809-2","volume":"22","author":"I Goranitis","year":"2020","unstructured":"Goranitis I, Best S, Christodoulou J, Stark Z, Boughtwood T. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments. Genet Medicine: Official J Am Coll Med Genet. 2020;22(8):1311\u20139.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"issue":"12","key":"3160_CR15","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1038\/s41436-019-0583-1","volume":"21","author":"DA Marshall","year":"2019","unstructured":"Marshall DA, MacDonald KV, Heidenreich S, Hartley T, Bernier FP, Gillespie MK, et al. The value of diagnostic testing for parents of children with rare genetic diseases. Genet Medicine: Official J Am Coll Med Genet. 2019;21(12):2798\u2013806.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"key":"3160_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.socscimed.2018.08.015","volume":"214","author":"C Peyron","year":"2018","unstructured":"Peyron C, Pelissier A, Bejean S. Preference heterogeneity with respect to whole genome sequencing. A discrete choice experiment among parents of children with rare genetic diseases. Soc Sci Med. 2018;214:125\u201332.","journal-title":"Soc Sci Med"},{"issue":"4","key":"3160_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JF Bridges","year":"2011","unstructured":"Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, et al. Conjoint analysis applications in health\u2013a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health: J Int Soc Pharmacoeconomics Outcomes Res. 2011;14(4):403\u201313.","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"5","key":"3160_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guideline. Genet Medicine: Official J Am Coll Med Genet. 2006;8(5):267\u201388.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"key":"3160_CR19","unstructured":"Kuhfeld W. Efficient experimental designs using computerized searches. 6th Sawtooth Software Conference; Aug 20\u201322,; Seattle, WA1997."},{"key":"3160_CR20","volume-title":"Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques","author":"W Kuhfeld","year":"2010","unstructured":"Kuhfeld W. Marketing research methods in SAS: experimental design, choice, conjoint, and graphical techniques. Cary, NC: SAS Institute Inc.; 2010."},{"key":"3160_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/002224379403100408","volume":"31","author":"W Kuhfeld","year":"1994","unstructured":"Kuhfeld W, Tobias F, Garratt M. Efficient experimental design with marketing research applications. J Mark Res. 1994;31:545\u201357.","journal-title":"J Mark Res"},{"issue":"12","key":"3160_CR22","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/hec.798","volume":"12","author":"T Maddala","year":"2003","unstructured":"Maddala T, Phillips KA, Reed Johnson F. An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ. 2003;12(12):1035\u201347.","journal-title":"Health Econ"},{"issue":"3","key":"3160_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jhealeco.2005.08.002","volume":"25","author":"DL Schwappach","year":"2006","unstructured":"Schwappach DL, Strasmann TJ. Quick and dirty numbers? The reliability of a stated-preference technique for the measurement of preferences for resource allocation. J Health Econ. 2006;25(3):432\u201348.","journal-title":"J Health Econ"},{"issue":"24","key":"3160_CR24","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/bloodadvances.2017007294","volume":"1","author":"C Mansfield","year":"2017","unstructured":"Mansfield C, Masaquel A, Sutphin J, Weiss E, Gutierrez M, Wilson J, et al. Patients\u2019 priorities in selecting chronic lymphocytic leukemia treatments. Blood Adv. 2017;1(24):2176\u201385.","journal-title":"Blood Adv"},{"key":"3160_CR25","doi-asserted-by":"crossref","unstructured":"Mansfield C, Sutphin J, Boeri M. Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow-up question. Health Econ. 2020.","DOI":"10.1002\/hec.4124"},{"key":"3160_CR26","unstructured":"Kruglanski AW, Atash MN, de Grada E, Mannetti L, Pierro A. Need for closure scale. Measurement Instrument Database for the Social Sciences; 2013."},{"issue":"3","key":"3160_CR27","first-page":"21","volume":"29","author":"Degner","year":"1997","unstructured":"Degner LF, Sloan JA, Venkatesh P. The Control preferences Scale. Can J Nurs Res = Revue canadienne de recherche en Sci Infirmieres. 1997;29(3):21\u201343.","journal-title":"Can J Nurs Res = Revue canadienne de recherche en Sci Infirmieres"},{"issue":"4","key":"3160_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jval.2018.12.007","volume":"22","author":"S Russo","year":"2019","unstructured":"Russo S, Jongerius C, Faccio F, Pizzoli SFM, Pinto CA, Veldwijk J, et al. Understanding patients\u2019 preferences: a systematic review of psychological instruments used in patients\u2019 preference and decision studies. Value Health: J Int Soc Pharmacoeconomics Outcomes Res. 2019;22(4):491\u2013501.","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"4","key":"3160_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"AB Hauber","year":"2016","unstructured":"Hauber AB, Gonz\u00e1lez JM, Groothuis-Oudshoorn CG, Prior T, Marshall DA, Cunningham C, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health: J Int Soc Pharmacoeconomics Outcomes Res. 2016;19(4):300\u201315.","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"3160_CR30","volume-title":"Discrete choice methods with simulation","author":"K Train","year":"2009","unstructured":"Train K. Discrete choice methods with simulation. Cambridge, UK: Cambridge University Press; 2009."},{"key":"3160_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/1-4020-3684-1_7","volume-title":"Application of simulation methods in environmental and resource economics","author":"K Train","year":"2005","unstructured":"Train K, Sonnier G. Mixed logit with bounded distributions of correlated partworths. In: Scarpa R, Alberini A, editors. Application of simulation methods in environmental and resource economics. Dordrecht, The Netherlands: Springer; 2005. pp. 117\u201334."},{"key":"3160_CR32","doi-asserted-by":"publisher","first-page":"997551","DOI":"10.3389\/fneur.2022.997551","volume":"13","author":"KWP Ng","year":"2022","unstructured":"Ng KWP, Chin HL, Chin AXY, Goh DL. Using gene panels in the diagnosis of neuromuscular disorders: a mini-review. Front Neurol. 2022;13:997551.","journal-title":"Front Neurol"},{"key":"3160_CR33","first-page":"E190","volume-title":"Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment","author":"DA Regier","year":"2015","unstructured":"Regier DA, Peacock SJ, Pataky R, van der Hoek K, Jarvik GP, Hoch J, et al. Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment. Volume 187. CMAJ: Canadian Medical Association journal\u2009=\u2009journal de l\u2019Association medicale canadienne; 2015. pp. E190\u20137. 6."},{"issue":"7","key":"3160_CR34","doi-asserted-by":"publisher","first-page":"e0179935","DOI":"10.1371\/journal.pone.0179935","volume":"12","author":"T Ploug","year":"2017","unstructured":"Ploug T, Holm S. Clinical genome sequencing and population preferences for information about \u2018incidental\u2019 findings-from medically actionable genes (MAGs) to patient actionable genes (PAGs). PLoS ONE. 2017;12(7):e0179935.","journal-title":"PLoS ONE"},{"issue":"2","key":"3160_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/gim.2017.93","volume":"20","author":"MA Lewis","year":"2018","unstructured":"Lewis MA, Stine A, Paquin RS, Mansfield C, Wood D, Rini C, et al. Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment. Genet Medicine: Official J Am Coll Med Genet. 2018;20(2):181\u20139.","journal-title":"Genet Medicine: Official J Am Coll Med Genet"},{"key":"3160_CR36","doi-asserted-by":"crossref","unstructured":"Schofield D, Alam K, Douglas L, Shrestha R, MacArthur DG, Davis M et al. Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases. NPJ Genomic Med. 2017;2.","DOI":"10.1038\/s41525-017-0006-7"},{"key":"3160_CR37","volume-title":"Rare diseases and orphan products: accelerating research and development. J. FM, F. BT","author":"Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development","year":"2010","unstructured":"Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development. Rare diseases and orphan products: accelerating research and development. J. FM, F. BT. editors. Washington, DC: National Academies; 2010."},{"key":"3160_CR38","doi-asserted-by":"crossref","unstructured":"Barp A, Mosca L, Sansone VA. Facilitations and hurdles of genetic testing in Neuromuscular disorders. Diagnostics (Basel). 2021;11(4).","DOI":"10.3390\/diagnostics11040701"},{"issue":"Suppl 2","key":"3160_CR39","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ejhg.5201111","volume":"11","author":"B Godard","year":"2003","unstructured":"Godard B, K\u00e4\u00e4ri\u00e4inen H, Kristoffersson U, Tranebjaerg L, Coviello D, Aym\u00e9 S. Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet. 2003;11(Suppl 2):S13\u201348.","journal-title":"Eur J Hum Genet"},{"key":"3160_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.reseneeco.2010.01.006","volume":"33","author":"JS Nielsen","year":"2011","unstructured":"Nielsen JS. Use of the internet for willingness-to-pay survey: a comparison of face-to-face and web-based interviews. Res Energy Econ. 2011;33:119\u201329.","journal-title":"Res Energy Econ"},{"issue":"3\u20134","key":"3160_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ecolecon.2007.02.005","volume":"62","author":"C Marta-Pedroso","year":"2007","unstructured":"Marta-Pedroso C, Freitas H, Domingos T. Testing for the survey mode effect on contingent valuation data quality: a case study of web based versus in-person interviews. Ecol Econ. 2007;62(3\u20134):388\u201398.","journal-title":"Ecol Econ"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03160-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03160-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T12:06:55Z","timestamp":1713787615000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03160-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3160"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03160-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was granted a review exemption from the RTI International Institutional Review Board and followed good research practice guidelines published by the International Society for Pharmacoeconomics and Outcomes Research. Participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CM is a full-time employee of RTI Health Solutions, an independent nonprofit research organization, which received funding pursuant to a contract from Sanofi to conduct the study that is the subject of this manuscript. MB and JC were employees of RTI Health Solutions at the time the study was conducted. SS, KAH, and AH are employees of Sanofi and may hold shares and\/or stock options in the company. EB was an employee of Sanofi at the time the study was conducted and may hold shares and\/or stock options in the company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}